This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Leger-Ravet, M. B. Articles by Emilie, D. Search for Related Content PubMed PubMed Citation Articles by Leger-Ravet, M. B. Articles by Emilie, D.

American Journal of Pathology, Vol 144, 492-499, Copyright © 1994 by American Society for Investigative Pathology

REGULAR ARTICLES

In situ detection of activated cytotoxic cells in follicular lymphomas

MB Leger-Ravet, O Devergne, M Peuchmaur, P Solal-Celigny, N Brousse, P Gaulard, P Galanaud and D Emilie
INSERM U131, Clamart, France.

The presence of cytotoxic cells and their activation status were analyzed in tissue sections of 26 follicular lymphomas. To this end, expression of the perforin and granzyme B genes was studied by in situ hybridization experiments, and expression of the TIA-1 antigen was analyzed by immunohistochemistry. Cells expressing the granzyme B gene and the perforin gene were detected in all cases. Their density was, however, highly heterogeneous from case to case, ranging from 160 to 7,040 positive cells/cm2 of tissue sections. TIA-1-positive cells were also evidenced in the 10 follicular lymphomas tested. Virtually all cytotoxic cells were located in interfollicular areas. Double labeling immunochemical experiments showed that most cytotoxic cells belonged to the CD8+ T lymphocyte population, although few CD4+ T lymphocytes and CD56+ natural killer cells also expressed the TIA-1 antigen. These findings show that development of a malignant B lymphocyte proliferation is associated with a host-derived immune response involving intratumoral cytotoxic T lymphocytes. Further studies comparing the density of such cells with the final outcome are required to determine whether the intensity of this immune response has a prognostic value.

This article has been cited by other articles:

				D. Focosi and M. Petrini CD57 Expression on Lymphoma Microenvironment As a New Prognostic Marker Related to Immune Dysfunction J. Clin. Oncol., April 1, 2007; 25(10): 1289 - 1291. [Full Text] [PDF]

				M. Guidoboni, C. Doglioni, L. Laurino, M. Boiocchi, and R. Dolcetti Activation of Infiltrating Cytotoxic T Lymphocytes and Lymphoma Cell Apoptotic Rates in Gastric MALT Lymphomas : Differences between High-Grade and Low-Grade Cases Am. J. Pathol., September 1, 1999; 155(3): 823 - 829. [Abstract] [Full Text] [PDF]

				S. Bauer, C. Renner, J.-P. Juwana, G. Held, S. Ohnesorge, K. Gerlach, and M. Pfreundschuh Immunotherapy of Human Tumors with T-Cell-activating Bispecific Antibodies: Stimulation of Cytotoxic Pathways in Vivo Cancer Res., April 1, 1999; 59(8): 1961 - 1965. [Abstract] [Full Text] [PDF]

				L. Krenacs, A. Wellmann, L. Sorbara, A. W. Himmelmann, E. Bagdi, E. S. Jaffe, and M. Raffeld Cytotoxic Cell Antigen Expression in Anaplastic Large Cell Lymphomas of T- and Null-Cell Type and Hodgkin's Disease: Evidence for Distinct Cellular Origin Blood, February 1, 1997; 89(3): 980 - 989. [Abstract] [Full Text] [PDF]

				C.-C. Liu, L. H.Y. Young, and J. D.-E Young Lymphocyte-Mediated Cytolysis and Disease N. Engl. J. Med., November 28, 1996; 335(22): 1651 - 1659. [Full Text] [PDF]